Kestra Medical Technologies Ltd (KMTS) financials
Kestra Medical Technologies revenue and earnings by year
Kestra Medical Technologies's revenue was $95.1 million in the fiscal year to April 30, 2026, up 59.0% from the year before. Net income was -$132 million, -138.4% of revenue. Since the fiscal year to April 30, 2023, revenue has grown 131.8% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 4 fiscal years
| Fiscal year to | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 |
|---|---|---|---|---|
| Revenue | 95 | 60 | 28 | 8 |
| Revenue growth | 59.0% | 115.1% | 264.5% | — |
| Gross profit | 49 | 24 | 0 | -11 |
| Gross margin | 51.4% | 40.5% | 1.3% | -139.6% |
| Operating income | -135 | -106 | -85 | -79 |
| Operating margin | -141.6% | -177.8% | -305.8% | -1030.1% |
| Net income | -132 | -114 | -94 | -84 |
| Net margin | -138.4% | -190.3% | -338.4% | -1104.0% |
| Diluted EPS | -$2.43 | -$5.13 | — | — |
| Free cash flow | -117 | -101 | -84 | -85 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open KMTS in Markets.
See also: KMTS returns
No forecast, no recommendation. This page describes Kestra Medical Technologies Ltd from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.